RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

Clinical trial NCT00402818 · TERMINATED

Trial details

NCT number: NCT00402818
Sponsor: Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Study type: OBSERVATIONAL

Plaque Psoriasis

Start date: 2006-05-01
Primary completion: 2009-07-01
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.